Natasha Giordano

Natasha Giordano, listed as chief executive, has filed trades across 3 companies (mainly through SEC (Form 4)), most often in Aceto Corp, Dendrite International Inc and PLx Pharma Inc. Over a trading history stretching from 25 April 2006 to 15 March 2022, the count stands at 21 filings.

In open-market terms, that means 1 purchase worth €14k on one side and 6 sales worth €124k on the other. Taken together, the sales exceed the purchases by €110k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 12 share grants. In 2022 alone, the filings show 1 purchase and no sales.

The newest entry dates from 16 March 2022: an open-market purchase of €14k, in PLx Pharma Inc. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.